Pregnancy and Pertussis: Why the Change in TDAP Administration? by Sperry, Marietta
Providence St. Joseph Health
Providence St. Joseph Health Digital Commons
Books, Presentations, Posters, Etc.
9-2015
Pregnancy and Pertussis: Why the Change in
TDAP Administration?
Marietta Sperry
Follow this and additional works at: https://digitalcommons.psjhealth.org/other_pubs
Part of the Nursing Commons, and the Obstetrics and Gynecology Commons
QUICK DESIGN GUIDE 
(--THIS SECTION DOES NOT PRINT--) 
 
This PowerPoint 2007 template produces a 36”x56” 
professional  poster. It will save you valuable time 
placing titles, subtitles, text, and graphics.  
 
Use it to create your presentation. Then send it to 
PosterPresentations.com for premium quality, same 
day affordable printing. 
 
We provide a series of online tutorials that will guide 
you through the poster design process and answer your 
poster production questions.  
 
View our online tutorials at: 
 http://bit.ly/Poster_creation_help  
(copy and paste the link into your web browser). 
 
For assistance and to order your printed poster call 





Use the placeholders provided below to add new 
elements to your poster: Drag a placeholder onto the 
poster area, size it, and click it to edit. 
 
Section Header placeholder 
Use section headers to separate topics or concepts 






Move this preformatted text placeholder to the poster 






Move this graphic placeholder onto your poster, size it 












RESEARCH POSTER PRESENTATION DESIGN © 2011 
www.PosterPresentations.com 
QUICK TIPS 
(--THIS SECTION DOES NOT PRINT--) 
This PowerPoint template requires basic PowerPoint 
(version 2007 or newer) skills. Below is a list of 
commonly asked questions specific to this template.  
If you are using an older version of PowerPoint some 
template features may not work properly. 
 
Using the template 
Verifying the quality of your graphics 
Go to the VIEW menu and click on ZOOM to set your 
preferred magnification. This template is at 100% the 
size of the final poster. All text and graphics will be 
printed at 100% their size. To see what your poster will 
look like when printed, set the zoom to 100% and 
evaluate the quality of all your graphics before you 
submit your poster for printing. 
 
Using the placeholders 
To add text to this template click inside a placeholder 
and type in or paste your text. To move a placeholder, 
click on it once (to select it), place your cursor on its 
frame and your cursor will change to this symbol:         
Then, click once and drag it to its new location where 
you can resize it as needed. Additional placeholders 
can be found on the left side of this template. 
 
Modifying the layout 
This template has four 
different column layouts.  
Right-click your mouse 
on the background and  
click on “Layout” to see  
the layout options. 
The columns in the provided layouts are fixed and 
cannot be moved but advanced users can modify any 
layout by going to VIEW and then SLIDE MASTER. 
 
Importing text and graphics from external sources 
TEXT: Paste or type your text into a pre-existing 
placeholder or drag in a new placeholder from the left 
side of the template. Move it anywhere as needed. 
PHOTOS: Drag in a picture placeholder, size it first, 
click in it and insert a photo from the menu. 
TABLES: You can copy and paste a table from an 
external document onto this poster template. To make 
the text fit better in the cells of an imported table, 
right-click on the table, click FORMAT SHAPE  then 
click on TEXT BOX and change the INTERNAL MARGIN 
values to 0.25 
 
Modifying the color scheme 
To change the color scheme of this template go to the 
“Design” menu and click on “Colors”. You can choose 














Student discounts are available on our Facebook page.  
Go to PosterPresentations.com and click on the FB icon. 
   Pregnancy and Pertussis-Why the Change in TDAP Administration? 
 
Previous recommendation of “cocooning” 
to prevent pertussis or “whooping cough” 
to newborns, (including the number of 
cases, hospitalizations & deaths) have not 
decreased the incidence in the newborn 
population and continues to rise. 2014 
was the highest number of cases since the 
introduction of the vaccine in the 1940’s.  
Increase historically has been seen 
cyclically every 4-5 years, and also is 
thought due to use of acelluar vaccine, 
which although not as long lasting, has 
less serious side effects than previously 






•  Patients not getting current 
information/asking for vaccine at sub 
optimal time. 
•  Patients not getting any information 
regarding Tdap vaccine. 
•  Cost of the vaccine to physicians/
physicians not carrying vaccine/not 
“having time” to inform patients. 
•  Cost of the vaccine to patients. 
•  Hospital staff not giving patients 








With a multi-faceted strategic approach 
involving:  
Ø Physician strong recommendation 
Ø Pre-natal education  
Ø  In-service of physician’s staff 
Ø Education of hospital staff  
Ø Use of an easy, physician/patient tool 
with Rx incorporated 
Compliance of Tdap administration during 
the appropriate time can be realized up to 
87%, which would decrease the incidence, 
hospitalizations, and deaths attributed to 
pertussis, or whooping cough in infants 
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Current	Sta4s4cs		
OLD 
Mothers vaccinated post partum:  
•  Prevention of 549 infant cases 
•  Prevention of 219 hospitalizations 
•  Prevention of 3 infant deaths. 
NEW 
Mothers vaccinated during pregnancy: 
•  Prevention of 906 infant cases. 
•  Prevention of 462 hospitalizations. 
•  Prevention of 9 infant deaths. 
No. of mothers reported getting Tdap info:                     
 50% 
No. of mothers reported receiving Tdap 
vaccination during pregnancy:  
 9%-18% 
No. of Newborns who get “whooping 
cough from: 
                    Mother-30%-40% 
             All family members 70%-80% 
   
Results	Old	vs.	New		(projected)		
Provide a Physician/Patient Tool with 
following elements: 
Ø  Locations that have vaccines available-ie., 
associated clinics or “Most Major Pharmacies” 
wording. Map if possible. 
Ø  CDC website with “vaccine finder” by zip code. 
Ø  Explanation of importance of vaccine. 
Ø  Prescription incorporated for convenience of 
physician to sign at bottom of tool. 
 
Give Physician/Patient Tool to Physician’s, 
and to patients at pre-natal education 
classes/tours to take to physician for Rx. 
 
Have CDC handout/posters posted & 
available in units where maternity 
patients frequent with current 
recommendation. 
 
Orient Physician to Physician/Patient Tool 
Ø  Provide Physicians who do not carry vaccine 1 
page brief intro to tool. 
 
Educate Physician’s Staff with in-service: 
Ø  Put Physician/Patient Tool on pregnant patients 
chart. 
Ø  Documentation of Tdap in pre-natals. 
Ø  Provide sticker/stamp for pre-natals to document 
patient receiving information, and/or reporting 
getting Tdap vaccination. 
 
Educate Hospital Staff on appropriate 
Tdap administration: 
Ø  Be mindful of orders to give to antepartum 
patients per CDC who haven’t had Tdap during 
pregnancy. 
Ø  Administer post-partum only if patient has never 
had Tdap or is due for 10 year booster and did 
not receive it during pregnancy. 
Ø  Give patient CDC vaccination Tdap information 














Prior recommendation: Vaccinate mother 
after delivery & all others in close contact 
with the newborn “cocooning.” 
Current recommendation (from Oct 2012):  
Vaccinate every mother during every 
pregnancy in 27th-36th week irrespective 
of prior Tdap vaccination history. 
 
The process involved the following: 
• Comprehensive search of materials/studies 
related to  pertussis in the newborn in 
CINHAL, PUB MED, Centers for Disease 
Control (CDC), and California Department of 
Public Health (CDPH). 
• Data was analyzed for history and current 
literature available on subject for last 5 
years. 
• Development of a universal Physician/ 
Patient Tool based on recommendations 
from literature search. 
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